Table 2 Proteins upregulated in BAL from controls, STAMPEDE subjects and a subset STAMPEDE subjects (21, 13, 46, 15, 9, 25, 17, 19, 36, 35), that were identified after cluster analysis (Figure 2 )
| Â | Control subjects | STAMPEDE subjects | Subset of STAMPEDE subjects | STAMPEDE vs CONTROLS | STAMPEDE subset vs controls | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Entrez ID | Mean | ST DEV | CV, % | Mean | ST DEV | CV, % | Mean | ST DEV | CV, % | p value | p value |
A1AG1 | 18.69 | 0.40 | 2.1 | 19.49 | 0.52 | 2.7 | 19.98 | 0.44 | 2.2 | 0.00055429 | 5.95509E-07 |
A1BG | 18.95 | 0.32 | 1.7 | 19.20 | 0.33 | 1.7 | 19.52 | 0.13 | 0.6 | 0.0001927 | 4.63441E-05 |
AACT | 17.34 | 0.50 | 2.9 | 17.99 | 0.35 | 2.0 | 18.37 | 0.13 | 0.7 | 0.0010359 | 6.39218E-06 |
ANT3 | 17.62 | 0.39 | 2.2 | 18.15 | 0.35 | 1.9 | 18.50 | 0.17 | 0.9 | 0.00037815 | 3.80627E-06 |
HEMO | 18.74 | 0.29 | 1.5 | 19.07 | 0.31 | 1.6 | 19.37 | 0.27 | 1.4 | 2.7297E-05 | 0.000126029 |
APOA1 | 17.42 | 1.22 | 7.0 | 18.53 | 0.91 | 4.9 | 19.10 | 0.52 | 2.7 | 9.4027E-05 | 0.000842961 |
APOA2 | 15.72 | 1.26 | 8.0 | 16.65 | 1.18 | 7.1 | 17.09 | 1.08 | 6.3 | 0.00057807 | 0.018670507 |
PZP | 17.01 | 0.99 | 5.8 | 17.86 | 0.71 | 4.0 | 18.27 | 0.57 | 3.1 | 3.3055E-05 | 0.003711976 |
A2MG | 16.74 | 0.85 | 5.1 | 17.24 | 0.63 | 3.6 | 17.56 | 0.59 | 3.4 | 1.9526E-05 | 0.024453179 |
HBA | 16.29 | 1.93 | 11.9 | 17.48 | 1.60 | 9.1 | 18.29 | 1.78 | 9.8 | 1.4869E-05 | 0.025085649 |
HBB | 15.96 | 1.94 | 12.1 | 17.67 | 1.51 | 8.6 | 18.42 | 1.71 | 9.3 | 7.2466E-06 | 0.006838885 |
HBD | 16.42 | 2.08 | 12.7 | 17.90 | 1.71 | 9.5 | 18.64 | 2.24 | 12.0 | 5.1691E-07 | 0.014381261 |